Augmentin is an effective antibiotic for many types of pneumonia, with clinical cure rates ranging from about 86% to 95% in trials. It is one of the preferred options in major treatment guidelines for community-acquired pneumonia, particularly when patients have other health conditions. However, it doesn’t cover every type of pneumonia, and some cases require a different antibiotic entirely.
When Guidelines Recommend Augmentin
The joint guidelines from the Infectious Diseases Society of America and the American Thoracic Society place amoxicillin-clavulanate (the generic name for Augmentin) among the preferred first-line treatments for outpatient pneumonia in adults who have comorbidities. That includes people with chronic heart, lung, liver, or kidney disease, diabetes, or weakened immune systems. In these cases, it’s typically paired with a second antibiotic from the macrolide class (like azithromycin) to broaden coverage.
For otherwise healthy adults with no recent antibiotic use and no chronic conditions, simpler antibiotics are usually tried first. Augmentin becomes the go-to option when there’s a higher risk of drug-resistant bacteria, which is more common in people with underlying health problems or those who’ve taken antibiotics in the past three months.
How Well It Works
FDA review data from multiple clinical trials show Augmentin achieves clinical cure rates between 86% and 95% in patients who completed a full course of treatment for community-acquired pneumonia. Even against penicillin-resistant strains of the most common pneumonia bacterium (Streptococcus pneumoniae), the high-dose extended-release formulation cured 93% of cases in the group that followed the protocol fully.
A separate study looking at bacteria isolated from severe pneumonia cases found that 97.9% of S. pneumoniae samples were susceptible to amoxicillin-clavulanate, along with 96.1% of Staphylococcus aureus and 84.6% of Haemophilus influenzae. These three are among the most frequent bacterial causes of pneumonia, which explains why Augmentin performs well across a broad range of cases.
What Augmentin Cannot Treat
Augmentin belongs to the beta-lactam family of antibiotics, which kill bacteria by attacking their cell walls. Some organisms that cause pneumonia simply don’t have cell walls, making them completely invisible to this drug. Mycoplasma pneumoniae, one of the most common causes of “walking pneumonia,” falls into this category. The CDC notes that all mycoplasmas are inherently resistant to beta-lactam antibiotics.
Legionella and Chlamydophila pneumoniae, two other causes of atypical pneumonia, are also outside Augmentin’s reach. This is precisely why guidelines recommend adding a macrolide antibiotic alongside Augmentin for patients with comorbidities. The macrolide covers the atypical organisms that Augmentin misses. If your doctor prescribes both, each one is handling a different set of potential culprits.
How Augmentin Compares to Other Options
In a comparative study of community-acquired pneumonia, amoxicillin and azithromycin showed similar clinical improvement rates by day six: 92.1% versus 85.5%. The difference was not statistically significant, meaning both antibiotics performed comparably. Radiographic clearing (improvement visible on chest X-ray) was also similar between the two groups.
The practical takeaway is that no single antibiotic is dramatically superior for typical bacterial pneumonia. The choice depends more on which bacteria are likely causing the infection, your allergy history, recent antibiotic use, and whether you have other health conditions. Augmentin’s advantage is its broader bacterial coverage compared to plain amoxicillin, thanks to the clavulanate component, which disables a common defense mechanism that some bacteria use to resist penicillin-type drugs.
Typical Dosage and Duration
For adults with lower respiratory tract infections like pneumonia, the standard dose is 500mg/125mg taken three times daily. In cases where drug-resistant bacteria are a concern, prescribers may use the extended-release formulation at 2000mg/125mg twice daily, which maintains higher antibiotic levels in the blood for longer periods. Treatment courses generally run 7 to 14 days, and guidelines advise against extending beyond 14 days without a clinical reassessment.
You’ll likely start feeling better within two to three days, but finishing the entire prescribed course matters. Stopping early, even when symptoms improve, gives surviving bacteria a chance to regrow and potentially develop resistance.
Side Effects to Expect
The most common side effect is diarrhea, and it’s not rare. Roughly one in three patients taking amoxicillin-clavulanate will develop it. The clavulanate component is the main driver, as it disrupts gut bacteria more aggressively than amoxicillin alone.
Research from MIT found that people with lower levels of certain protective gut bacteria (from the Ruminococcaceae family) before starting treatment were more likely to develop diarrhea. This suggests the side effect isn’t random; it depends partly on your existing gut microbiome. Taking the medication with food can reduce stomach upset. Nausea and abdominal discomfort are also common but typically mild.
If diarrhea becomes severe, watery, or contains blood, that warrants prompt medical attention, as it could signal a more serious gut infection called C. difficile colitis, which occasionally occurs with any antibiotic use.
Why Your Doctor Might Choose Something Else
Several situations make Augmentin a poor fit. If you have a penicillin allergy, it’s off the table entirely since amoxicillin is a penicillin-type drug. If atypical pneumonia is strongly suspected based on your age, symptoms, or exposure history, a macrolide or doxycycline alone may be more appropriate. For severe pneumonia requiring hospitalization, intravenous antibiotics with broader coverage are the standard approach.
Previous antibiotic use also matters. If you’ve taken a beta-lactam antibiotic in the past three months, guidelines recommend switching to a different class to reduce the chance of encountering resistant bacteria. Your prescriber factors all of this in when choosing which antibiotic matches your specific situation.